[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

March 2019 | 68 pages | ID: A5D0AE11A44EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virology and metabolic therapy areas. The company also offers medicines for neurological disorders and other serious health conditions. AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies. The company commercializes its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses across the world. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc Key Recent Developments

Feb 27,2019 Top pharma executives testify before US Senate over high prices
Feb 25,2019 AbbVie and Voyager deepen alliance to include Parkinson’s
Feb 19,2019 Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
Feb 19,2019 FTC enters global settlement to resolve reverse-payment charges against Teva

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

AbbVie Inc - Key Facts
AbbVie Inc - Key Employees
AbbVie Inc - Key Employee Biographies
AbbVie Inc - Major Products and Services
AbbVie Inc - History
AbbVie Inc - Company Statement
AbbVie Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AbbVie Inc - Business Description
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: Canada
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: United States
Performance
R&D Overview
AbbVie Inc - Corporate Strategy
AbbVie Inc - SWOT Analysis
SWOT Analysis - Overview
AbbVie Inc - Strengths
AbbVie Inc - Weaknesses
AbbVie Inc - Opportunities
AbbVie Inc - Threats
AbbVie Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
AbbVie Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 27, 2019: Top pharma executives testify before US Senate over high prices
Feb 25, 2019: AbbVie and Voyager deepen alliance to include Parkinson’s
Feb 19, 2019: Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
Feb 19, 2019: FTC enters global settlement to resolve reverse-payment charges against Teva
Feb 12, 2019: AbbVie and Teneobio to co-develop new drug for multiple myeloma
Feb 05, 2019: US Senate invites seven pharma majors to testify on price hikes
Jan 28, 2019: AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®) - First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Jan 25, 2019: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
Jan 18, 2019: https://news.abbvie.com/news/press-releases/abbvie-provides-update-on-phase-3-study-ibrutinib-imbruvica-in-metastatic-pancreatic-cancer.htm
Jan 18, 2019: AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA) in Metastatic Pancreatic Cancer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

AbbVie Inc, Key Facts
AbbVie Inc, Key Employees
AbbVie Inc, Key Employee Biographies
AbbVie Inc, Major Products and Services
AbbVie Inc, History
AbbVie Inc, Subsidiaries
AbbVie Inc, Key Competitors
AbbVie Inc, Ratios based on current share price
AbbVie Inc, Annual Ratios
AbbVie Inc, Annual Ratios (Cont.1)
AbbVie Inc, Annual Ratios (Cont.2)
AbbVie Inc, Interim Ratios
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
AbbVie Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

AbbVie Inc, Performance Chart (2014 - 2018)
AbbVie Inc, Ratio Charts
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
AbbVie Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Amgen Inc
Bristol-Myers Squibb Co
Eli Lilly and Co
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co Inc
Novartis AG
Pfizer Inc


More Publications